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Abstract
Background:  Incidence of diabetes, obesity and insulin resistance are associated with high
glycemic load diets. Identifying food components that decrease post-prandial glycemia may be
beneficial for developing low glycemic foods and supplements. This study explores the glycemic
impact of adding escalating doses of a glycemic index lowering peptide fraction (GILP) from whey
to a glucose drink.
Methods: Ten healthy subjects (3M, 7F, 44.4 ± 9.3 years, BMI 33.6 ± 4.8 kg/m2) participated in an
acute randomised controlled study. Zero, 5, 10 and 20 g of protein from GILP were added to a 50
g glucose drink. The control (0 g of GILP) meal was repeated 2 times. Capillary blood samples were
taken fasting (0 min) and at 15, 30, 45, 60, 90 and 120 minutes after the start of the meal and
analyzed for blood glucose concentration.
Results: Increasing doses of GILP decreased the incremental areas under the curve in a dose
dependant manner (Pearson's r = 0.48, p = 0.002). The incremental areas (iAUC) under the glucose
curve for the 0, 5, 10, and 20 g of protein from GILP were 231 ± 23, 212 ± 23, 196 ± 23, and 138
± 13 mmol.min/L respectively. The iAUC of the 20 g GILP was significantly different from control,
5 g GILP and 10 g GILP (p < 0.001). Average reduction in the glucose iAUC was 4.6 ± 1.4 mmol.min/
L per gram of ingested GILP.
Conclusion: Addition of GILP to a oral glucose bolus reduces blood glucose iAUC in a dose
dependent manner and averages 4.6 ± 1.4 mmol.min/L per gram of GILP. These data are consistent
with previous research on the effect of protein on the glycemic response of a meal.
Background
The rate of glucose absorption and the duration of ele-
vated blood glucose levels induce many hormonal and
metabolic changes that may affect health or disease
parameters. Low glycemic index (GI) diets may help in
weight maintenance and weight loss [1] in addition to
being protective against chronic disease such as diabetes
[2], heart disease [3,4] and certain cancers [5,6]. Interest
in identifying low GI foods and the food factors responsi-
ble for the low GI of foods has therefore increased. Several
food factors have been identified that influence in vivo
absorption and therefore potentially the GI of a food or
meal. Some of these factors include: the food matrix, cell
wall and starch structure (i.e. ripening), amylose to amy-
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lopectin ratio, protein-starch interaction, processing and
dietary fibre [7].
More recently, interest has focused on the metabolic
responses to dietary proteins. Proteins vary in their ability
to decrease post-prandial glycemia. Comparing the insuli-
notropic characteristics of milk, gluten, cod, cheese and
whey demonstrated that both milk and whey have the
greatest impact on glucose metabolism by increasing both
insulin secretion and glucose-dependent insulinotropic
polypeptide (GIP) [8].
Milk protein, in particular, appears to stimulate an
increase in postprandial insulin response with a corre-
sponding reduction in postprandial blood glucose levels
[9,10]. Studies exploring the insulinotropic effect of the
dairy protein have found that the whey fraction seems to
contain the predominating insulinotropic secretagogue
[8,11,12].
Different sources of protein may be digested at different
rates; with whey being one of the most rapidly digested
resulting in high postprandial concentrations of amino
acids [9]. Individual amino acids may act as potent insulin
secretagogues [13,14] and in particular, leucine, isoleu-
cine, valine, lysine and threonine have been proposed as
the most likely amino acids responsible for the increase
seen in insulin concentrations [8]. It is not known if addi-
tion of whey protein will consistently lower postprandial
blood glucose responses and whether this lowering hap-
pens in a dose responsive manner.
This study was therefore conducted to measure the impact
of a glycemic index lowering peptide ingredient given in
escalating doses to a glucose drink on post prandial glyc-
emia and to calculate the relative glycemic lowering abil-
ity of this protein fraction.
Methods
Subjects
Ten healthy subjects participated in the study consisting
of 3 males and 7 females with an average age of (Mean ±
SD) 44.4 ± 9.3 years. The body mass index of the subjects
ranged from 26.7 to 41.1 kg/m2, the average being 33.6 ±
4.8 kg/m2. Subjects were recruited through the Glycemic
Index Laboratories clinic volunteer roster. The study was
approved by the Western Institutional Review Board,
Washington. Informed written consent was obtained
from all subjects prior to the start of the study. Subjects
received a financial reward for their participation. All 6
treatments were completed on separate days with at least
one day between tests.
Test Meals
The test meals (Table 1) consisted of 250 ml of water
blended with 50 g of anhydrous glucose (control), 50 g of
glucose + 5.6 g GILP powder (5 g GILP protein), 50 g of
glucose + 11.2 g GILP powder (10 g GILP protein) and 50
Table 1: Composition of the different meals.
Component Control 5 g GILP 10 g GILP 20 g GILP
Protein (g) 05 1 0 2 0
Leucine (g) 0 0.56 1.12 2.24
Isoleucine (g) 0 0.36 0.72 1.44
Valine (g) 0 0.32 0.63 1.26
Total BCAA 0 1.24 2.47 4.94
Lysine 0 0.48 0.96 1.92
Cysteine 0 0.13 0.25 0.5
Methionine 0 0.10 0.21 0.42
Tryptophan 0 0.11 0.22 0.44
Phenylalanine 0 0.16 0.32 0.64
Histidine 0 0.09 0.19 0.38
Threonine 0 0.40 0.80 1.60
Arginine 0 0.08 0.16 0.32
Tyrosine 0 0.16 0.31 0.62
Lipid (g) 0 0.03 0.06 0.12
Carbohydrate (g) 50 50 50 50
Lactose (g) 0 0.07 0.14 0.28
Minerals
Calcium (mg) 0 121 241 482
Phosphorus (mg) 0 63 127 254
Sodium (mg) 0 53 107 214
Potassium (mg) 0 25 50 100
Magnesium (mg) 0 13 25 50
Zinc (ug) 0 15 30 60Nutrition Journal 2009, 8:47 http://www.nutritionj.com/content/8/1/47
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g of glucose + 22.5 g GILP powder (20 g GILP protein).
Testing of the various meals was done in a randomized
fashion. The control glucose meal was repeated 2 times by
each subject and the average was calculated.
Protein Supplement
The protein supplement (Glanbia, Twin Falls, ID USA)
consisted of a blend of whey peptides and intact whey
protein containing a high concentration of branch chain
amino acids. Doses were calculated to contain 5, 10 and
20 g of protein.
Protocol
On each test day, subjects came to Glycemic Index Labo-
ratories, Inc. in the morning after a 10-14 h overnight fast.
After being weighed and having a fasting blood sample
obtained by finger-prick, the subject then consumed a test
meal within 10 minutes, and further blood samples were
obtained at 15, 30, 45, 60, 90 and 120 minutes after the
start of the test meal.
A beverage of choice was served to each subject with each
test meal, comprising of one or two cups of water, tea or
coffee with or without milk. The same beverage was served
to the subject at each of the subsequent test meals.
Data Analysis
The incremental area under the plasma glucose response
curve (iAUC) for each of the test meals for each subject
was calculated using the trapezoid rule and not using the
area under the baseline [15]. The mean of the two glucose
meals (control) was used in statistical analysis and the
intra-individual coefficient of variation and intraclass
coefficient of correlation of the two OGTTs were calcu-
lated. Differences between the meals were assessed using
repeated-measures analysis of variance (ANOVA) and
adjusted for multiple pair-wise comparisons with the
Tukey-Kramer procedure. Relationship between glucose
iAUC levels and GILP dose was calculated using the Pear-
son's correlation and linear regression to estimate the
reduction in iAUC per gram of GILP. All data are
expressed as Mean ± SEM.
Results
The means of the iAUC of the two glucose controls were
237 ± 25 and 225 ± 24 mmol/L·min. The intra-individual
coefficient of variation and intra-class coefficient of corre-
lation of the repeated control glucose test meals were
28.3% and 17.9% respectively.
Glucose iAUC levels correlated inversely with GILP doses,
indicating that higher doses of GILP resulted in lower
blood glucose levels (Pearson's r = -0.48, p = 0.002). Lin-
ear regression analysis showed significant dose-response
decrease in blood glucose iAUC with increasing doses of
GILP (slope = -4.6 ± 1.4; t = -3.4; p = 0.002; Y = 235-4.6X;
r2 = 0.23).
Blood glucose concentrations were significantly reduced
at 30, 45 and 60 minutes after the 20 g GILP protein meal
when compared to control (Figure 1). The blood glucose
levels after the 20 g GILP meal were also lower than the 5
g GILP meal at 45 min and both the 5 g and 10 g GILP
meals at 60 min (p < 0.001). Incremental areas under the
curve (iAUC) for the GILP plus glucose meals of 0, 5, 10
and 20 g of protein were 231 ± 23, 212 ± 23, 196 ± 23, and
138 ± 13 mmol/L·min respectively. The iAUC of 20 g
GILP protein plus glucose meal was significantly lower
than the glucose control, 5 g GILP protein and 10 g GILP
protein meals (p < 0.001) (Figure 2). The 5, 10 and 20 g
doses of protein reduced the iAUC by 7.6, 13.3 and 37.5%
respectively.
Discussion
This study demonstrated that addition of this unique gly-
cemic index lowering peptide whey-based protein reduces
postprandial glycemia in a dose-dependent manner when
added to a 50 g glucose drink. The exact mechanism is not
known but it has been postulated that the blood glucose
lowering is a result of an increase of insulin secretion
[11,12]. In studies where protein is combined with carbo-
Incremental blood glucose response after meals containing  either glucose alone (control), or glucose plus either 5, 10 or  20 g of protein from GILP Figure 1
Incremental blood glucose response after meals con-
taining either glucose alone (control), or glucose plus 
either 5, 10 or 20 g of protein from GILP. Data are 
expressed as Mean ± SEM. * 20 g GILP meal significantly dif-
ferent from control, ** 20 g GILP different from 5 g GILP and 
control, *** 20 g GILP different from all meals using GLM 
ANOVA and adjusted for multiple pair-wise comparisons 
with the Tukey-Kramer test (p < 0.001).
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hydrate, an enhancement of the insulin response is
observed [11,16].
The differential effect of different amino acids on post-
prandial insulin levels is well known, it is therefore likely
that protein mixes with different amino acid profiles will
elicit different postprandial insulin responses. Whey pro-
tein is particularly high in branch-chain amino acids, in
particular leucine [17]. These amino acids are insulino-
genic, meaning that they have a higher capacity to increase
an insulin response [18], which may account for the
results seen in this study. Another possibility is the effect
of whey protein on incretin hormones released in the gut
[19,20]. Incretin hormones such as Glucagon-like-pep-
tide-1 (GLP-1) and Glucose-dependent insulinotropic
peptide (GIP) are released from the gut after food con-
sumption and are involved in many digestive roles includ-
ing glycemic control.
Glucagon-like peptide-1 (GLP-1) is a multi-functioning
hormone which is released from the gut in response to a
meal. Exogenous GLP-1 stimulates insulin secretion and
individuals with diabetics have lower levels of GLP-1
secretion [21].
Dipeptidyl peptidase IV (DPP-IV) is a peptidase which
hydrolyzes incretin hormones like GLP-1. Inhibiting DPP-
IV in rats with an inhibitor has been shown to suppress
blood glucose elevation by possibly protecting GLP-1
[22]. One important role whey protein may play is in the
physiology of incretin hormones. Whey protein has been
shown in mice to raise GLP-1 and inhibit DPP-IV resulting
in an increased and prolonged insulin response [19,20].
Measurement of these hormones after ingestion of meals
containing GILP may help elucidate the mechanism of
action of the glucose reduction seen with this whey pep-
tide fraction.
Conclusion
In conclusion, this unique glycemic index lowering pep-
tide whey based protein significantly lowered the glyc-
emic response elicited by 50 g of glucose in a dose
dependent manner. The reduction in blood glucose iAUC
per gram of protein powder was calculated to be 4.6 ± 1.4
mmol.min/L. Addition of GILP to carbohydrate food
products may be an effective way of lowering the glycemic
impact of these foods.
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